— 14th Annual Healthcare Conference —
Oxford, UK – 29 August 2012: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that John Dawson, Chief Executive Officer of Oxford BioMedica, will present at the Rodman & Renshaw Annual Global Investment Conference to be held on September 9-11, 2012 at The Waldorf Astoria, NY (USA).
The presentation is scheduled for Monday, 10 September 2012 at 16:30 Eastern Time. A copy of the slide presentation will be made available on the “Investors/Corporate presentations” section of the Company’s website at www.oxfordbiomedica.co.uk.
-Ends-